JPMorgan Chase & Co’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-78
| Closed | – | – | 6318 |
|
|
2022
Q4 | $0 | Buy |
+78
| New | – | ﹤0.01% | 6167 |
|
|
2022
Q3 | – | Sell |
-1,498
| Closed | -$9K | – | 6023 |
|
|
2022
Q2 | $9K | Sell |
1,498
-19,837
| -93% | -$119K | ﹤0.01% | 5207 |
|
|
2022
Q1 | $76K | Buy |
21,335
+12,891
| +153% | +$45.9K | ﹤0.01% | 4858 |
|
|
2021
Q4 | $42K | Buy |
+8,444
| New | +$42K | ﹤0.01% | 5133 |
|
|
2020
Q3 | – | Sell |
-558
| Closed | -$3K | – | 5112 |
|
|
2020
Q2 | $3K | Sell |
558
-11,815
| -95% | -$63.5K | ﹤0.01% | 4615 |
|
|
2020
Q1 | $46K | Buy |
12,373
+8,118
| +191% | +$30.2K | ﹤0.01% | 4165 |
|
|
2019
Q4 | $27K | Sell |
4,255
-11,075
| -72% | -$70.3K | ﹤0.01% | 4384 |
|
|
2019
Q3 | $215K | Buy |
15,330
+9,064
| +145% | +$127K | ﹤0.01% | 3720 |
|
|
2019
Q2 | $98K | Buy |
6,266
+1,641
| +35% | +$25.7K | ﹤0.01% | 4033 |
|
|
2019
Q1 | $194K | Buy |
4,625
+1,111
| +32% | +$46.6K | ﹤0.01% | 3772 |
|
|
2018
Q4 | $146K | Buy |
3,514
+336
| +11% | +$14K | ﹤0.01% | 3911 |
|
|
2018
Q3 | $153K | Buy |
3,178
+2,614
| +463% | +$126K | ﹤0.01% | 3960 |
|
|
2018
Q2 | $27K | Buy |
+564
| New | +$27K | ﹤0.01% | 4479 |
|